Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-1-24
pubmed:abstractText
Patients with neutropenia and persistent fever are often treated empirically with amphotericin B or liposomal amphotericin B to prevent invasive fungal infections. Antifungal triazoles offer a potentially safer and effective alternative.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1533-4406
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
346
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
225-34
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11807146-Adolescent, pubmed-meshheading:11807146-Adult, pubmed-meshheading:11807146-Aged, pubmed-meshheading:11807146-Aged, 80 and over, pubmed-meshheading:11807146-Amphotericin B, pubmed-meshheading:11807146-Anti-Bacterial Agents, pubmed-meshheading:11807146-Antifungal Agents, pubmed-meshheading:11807146-Child, pubmed-meshheading:11807146-Chronic Disease, pubmed-meshheading:11807146-Drug-Induced Liver Injury, pubmed-meshheading:11807146-Female, pubmed-meshheading:11807146-Fever, pubmed-meshheading:11807146-Humans, pubmed-meshheading:11807146-Infusions, Intravenous, pubmed-meshheading:11807146-Male, pubmed-meshheading:11807146-Middle Aged, pubmed-meshheading:11807146-Mycoses, pubmed-meshheading:11807146-Neoplasms, pubmed-meshheading:11807146-Neutropenia, pubmed-meshheading:11807146-Prospective Studies, pubmed-meshheading:11807146-Pyrimidines, pubmed-meshheading:11807146-Triazoles
pubmed:year
2002
pubmed:articleTitle
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
pubmed:affiliation
National Cancer Institute, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study